Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
59.06 USD | -1.11% | +9.30% | -5.61% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.61% | 5.07B | |
+57.32% | 59.34B | |
+42.95% | 40.24B | |
-5.47% | 39.88B | |
-5.56% | 28.55B | |
+16.08% | 27.26B | |
-21.01% | 19.23B | |
+32.08% | 12.61B | |
+3.09% | 12.49B | |
+26.22% | 12.28B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Barclays Adjusts Price Target on CRISPR Therapeutics to $67 From $80, Maintains Equal-Weight Rating